MONROE CLINIC — History
CCN 520028 | 3-year financial timeline | COVID resilience: 74/100
🛡️ Public data only — no PHI permitted on this instance.
$195M
Latest Revenue (FY2022)
+8.9%
Revenue CAGR (3yr)
-4.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $165M | $191M | $195M | +2.0% | +8.9% |
| Operating Expenses | $184M | $200M | $204M | +2.1% | +5.2% |
| Operating Margin | -11.9% | -4.3% | -4.4% | -1.0% | +0.0% |
| Net Income | $-20M | $-8M | $-9M | -3.1% | +0.0% |
| Licensed Beds | 58 | 58 | 58 | +0.0% | +0.0% |
| Total Patient Days | 7,811 | 9,399 | 9,020 | -4.0% | +7.5% |
| Medicare Day % | 41% | 34% | 36% | +4.9% | -7.2% |
| Medicaid Day % | 8% | 5% | 5% | -11.0% | -21.1% |
COVID Impact & Recovery
Resilience Score: 74/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +18.6% ($165M → $195M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+8.9%
This Hospital
+7.6%
State Avg
Latest Margin
-4.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $211M | -0.6% |
| FY2024 (proj) | $226M | 3.2% |
| FY2025 (proj) | $241M | 6.9% |